Ken Griffin’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.2M Sell
962,603
-4,613,658
-83% -$167M ﹤0.01% 1915
2026
Q2
$197M Buy
5,576,261
+3,060,263
+122% +$90.4M 0.02% 561
2026
Q1
$69.7M Buy
2,515,998
+229,997
+10% +$5.91M 0.01% 1089
2025
Q4
$49.6M Buy
2,286,001
+1,317,798
+136% +$26M 0.01% 1421
2025
Q3
$14.6M Buy
968,203
+476,071
+97% +$5.89M ﹤0.01% 2725
2025
Q2
$5.55M Sell
492,132
-859,209
-64% -$9.31M ﹤0.01% 3923
2025
Q1
$13.6M Sell
1,351,341
-453,438
-25% -$4.9M ﹤0.01% 2479
2024
Q4
$21.4M Sell
1,804,779
-4,123,404
-70% -$48.8M ﹤0.01% 2095
2024
Q3
$68.4M Buy
5,928,183
+4,004,146
+208% +$45.6M 0.01% 965
2024
Q2
$20.3M Sell
1,924,037
-1,215,542
-39% -$13.3M ﹤0.01% 1984
2024
Q1
$33.1M Sell
3,139,579
-342,124
-10% -$3.69M 0.01% 1566
2023
Q4
$39.1M Buy
3,481,703
+3,355,500
+2,659% +$32.7M 0.01% 1370
2023
Q3
$1.47M Buy
126,203
+101,024
+401% +$1.14M ﹤0.01% 5805
2023
Q2
$254K Sell
25,179
-1,378,661
-98% -$12.3M ﹤0.01% 9378
2023
Q1
$10.4M Buy
1,403,840
+539,869
+62% +$4.45M ﹤0.01% 2780
2022
Q4
$6.9M Sell
863,971
-570,054
-40% -$3.17M ﹤0.01% 3349
2022
Q3
$4.62M Buy
1,434,025
+1,246,676
+665% +$4.83M ﹤0.01% 4005
2022
Q2
$762K Buy
+187,349
New +$744K ﹤0.01% 7653

Other funds holding ROIV

Ken Griffin's ROIV Position: Q3 2026 in Review

Ken Griffin reduced its Roivant Sciences (ROIV) stake by 83% in Q3 2026, selling an estimated $167M and leaving 962,603 shares worth $35.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Ken Griffin first reported a position in ROIV in Q2 2022 and has held it in 18 quarters since. The position peaked at $197M in Q2 2026. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Ken Griffin held 962,603 shares of Roivant Sciences worth $35.2M as of Q3 2026.
  • Ken Griffin sold 4,613,658 Roivant Sciences shares in Q3 2026, an estimated $167M.
  • Roivant Sciences made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1915 holding.
  • Ken Griffin first reported a position in Roivant Sciences in Q2 2022 and has held it in 18 quarters since.
  • Ken Griffin's Roivant Sciences position peaked at $197M in Q2 2026.
  • 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.